Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plinabulin vs Pegfilgrastim for Neutropenia in Breast Cancer
NCT04227990Phase 2Completed
- Sponsor
- BeyondSpring Inc.
- Start
- Nov 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of plinabulin in chemotherapy-induced neutropenia (CIN), sponsored by BeyondSpring Inc.. Started Nov 2017; status: completed.
02
Drugs
plinabulin
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT04227990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04227990.